Growth Metrics

Wave Life Sciences (WVE) Net Income Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -115.33%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -73.01%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Wave Life Sciences 1.32 Bn 772.50 Mn - 44.35%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 44.35%
Dec 31, 2025 -281.79%
Sep 30, 2025 12.83%
Jun 30, 2025 -53.29%
Mar 31, 2025 -48.55%
Dec 31, 2024 279.70%
Sep 30, 2024 -951.90%
Jun 30, 2024 -56.00%
Mar 31, 2024 -15.15%
Dec 31, 2023 62.76%
Sep 30, 2023 118.59%
Jun 30, 2023 48.90%
Mar 31, 2023 27.53%
Dec 31, 2022 -25.65%
Sep 30, 2022 -526.07%
Jun 30, 2022 -6.53%
Mar 31, 2022 10.95%
Dec 31, 2021 -20.66%
Sep 30, 2021 81.18%
Jun 30, 2021 4.35%
Mar 31, 2021 10.59%
Dec 31, 2020 49.22%
Sep 30, 2020 34.75%
Jun 30, 2020 3.37%
Mar 31, 2020 -7.45%
Dec 31, 2019 -49.84%
Sep 30, 2019 -34.80%
Jun 30, 2019 -16.85%
Mar 31, 2019 -25.42%
Dec 31, 2018 -26.78%
Sep 30, 2018 -47.61%
Jun 30, 2018 -45.93%
Mar 31, 2018 -67.05%
Dec 31, 2017 -59.70%
Sep 30, 2017 -45.39%
Jun 30, 2017 -112.68%
Mar 31, 2017 -168.84%
Dec 31, 2016 -163.60%
Sep 30, 2016 -255.25%
Jun 30, 2016 -212.57%
Mar 31, 2016 -126.46%
Dec 31, 2015 -305.89%
Sep 30, 2015 -262.14%